Predictimmune Revenue and Competitors

Cambridge,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Predictimmune's estimated annual revenue is currently $2.8M per year.(i)
  • Predictimmune's estimated revenue per employee is $162,000

Employee Data

  • Predictimmune has 17 Employees.(i)
  • Predictimmune grew their employee count by 13% last year.

Predictimmune's People

NameTitleEmail/Phone
1
Director Product OperationsReveal Email/Phone
2
Executive Director Medical Affairs and Market AccessReveal Email/Phone
3
Product Operations Manager (Principal Scientist)Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$54.4M1836%N/AN/A
#2
$18M74-4%N/AN/A
#3
$162.7M48239%N/AN/A
#4
$42.8M1448%N/AN/A
#5
$26.5M984%N/AN/A
#6
$33.2M123-2%N/AN/A
#7
$29.7M11012%N/AN/A
#8
$15.5M66-21%$29.7MN/A
#9
$1645.8M435413%N/AN/A
#10
$43.7M14718%N/AN/A
Add Company

What Is Predictimmune?

PredictImmune develops pioneering tools for guiding personalised treatment options in immune-mediated diseases such as inflammatory bowel disease (IBD). Based on world-leading research at Cambridge University, UK, we are developing a simple lab test, using a small blood sample, which accurately identifies patients at diagnosis who are at risk of experiencing severe, relapsing disease. These patients are likely to benefit from early biologics therapy. Physicians, patients and payers all recognise the value of such an approach to the management of inflammatory bowel disease (IBD). www.predictimmune.com

keywords:N/A

N/A

Total Funding

17

Number of Employees

$2.8M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Predictimmune News

2022-04-17 - Cell-Free DNA as Disease Biomarkers

Circulating mitochondrial DNA dynamics in preeclampsia; Cell-free biomarkers to predict immune-related complications of COVID-19,...

2022-03-30 - New NHS blood test provides hope for Crohn's disease sufferers

... by Cambridge University scientists and produced by company PredictImmune, and said more research was needed before it could be approved.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.5M17-78%$305.9M
#2
$3.5M17-6%N/A
#3
$1.5M17N/AN/A
#4
$1.5M176%N/A
#5
$2.6M170%N/A